3,779 followers
New paper from CRD authors: Tisagenlecleucel for the treatment of relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years: an Evidence Review Group perspective of a NICE Single Technology Appraisal https://t.co/HrTHOsfHhP